HRP-3, also known as Human Ribosomal Protein 3, plays a pivotal role in protein synthesis within the cell. As a component of the ribosome, HRP-3 is essential for the translation of mRNA into proteins, thereby contributing to various cellular processes crucial for cell growth, proliferation, and maintenance of homeostasis. Specifically, HRP-3 is involved in the assembly of the ribosomal subunits and the recognition of the start codon on mRNA, facilitating the initiation of protein synthesis. Furthermore, HRP-3 interacts with other ribosomal proteins and ribosomal RNA to form the functional ribosome complex, ensuring the fidelity and efficiency of translation.
Inhibition of HRP-3 can have profound effects on cellular function and viability due to its central role in protein synthesis. Various mechanisms can lead to the inhibition of HRP-3 activity, disrupting the translation process and impairing cellular functions. One common mechanism involves the interference with ribosome assembly or stability, impeding the proper formation of functional ribosomes. Additionally, inhibition of HRP-3 can occur through interference with its interactions with other ribosomal components or mRNA, hindering the initiation or elongation phases of protein synthesis. Moreover, compounds targeting HRP-3 may disrupt its enzymatic activity or induce conformational changes that render it inactive, further inhibiting protein synthesis and leading to cellular dysfunction. Overall, understanding the mechanisms of HRP-3 inhibition is crucial for elucidating its role in cellular physiology and exploring strategies targeting protein synthesis in various disease contexts.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A potent kinase inhibitor that can inhibit a wide range of protein kinases, potentially affecting the phosphorylation state of HDGFRP3 or its interacting partners. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor that could alter signaling pathways in which HDGFRP3 may be involved, thereby affecting its function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor that can disrupt JNK-mediated signaling processes, potentially impacting HDGFRP3's role if it is JNK-dependent. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAPK inhibitor that could modulate cellular responses in which HDGFRP3 might participate. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Another PI3K inhibitor that can alter signaling cascades, potentially influencing HDGFRP3 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor that may affect cellular growth and proliferation pathways, potentially impacting HDGFRP3's function. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
A proteasome inhibitor that can affect the degradation of proteins and may indirectly influence HDGFRP3 stability. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
A tyrosine kinase inhibitor that could affect kinase-mediated signaling pathways where HDGFRP3 may be involved. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
A Raf kinase inhibitor that might also inhibit other kinases, potentially affecting pathways linked to HDGFRP3. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
A Src kinase inhibitor that could disrupt Src family kinase signaling, possibly influencing HDGFRP3's activity. | ||||||